terbutaline has been researched along with pentagastrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gomez, G; Greeley, GH; Izukura, M; Kogire, M; Thompson, JC; Uchida, T | 1 |
| Feldman, M; Fredrickson, MA; Richardson, CT; Stevens, MH; Thirlby, RC; Unger, RH | 1 |
1 review(s) available for terbutaline and pentagastrin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for terbutaline and pentagastrin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.
Topics: Animals; Dogs; Female; Gastric Acid; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Male; Pentagastrin; Peptide YY; Peptides; Receptors, Adrenergic, beta; Terbutaline; Time Factors | 1990 |
Inhibitory effects of beta-adrenergic agonists on gastric acid secretion in dogs.
Topics: Adrenergic beta-Agonists; Animals; Bethanechol; Bethanechol Compounds; Dogs; Gastric Acid; Gastrins; Histamine; Isoproterenol; Male; Pentagastrin; Peptides; Terbutaline; Vagotomy | 1986 |